You are here

Continuing Education Credit

An Evidence-Based Summary of Insulin Analogues

Bethany A. Fedutes, PharmD, Amy Calabrese Donihi, PharmD, BCPS, Colleen M. Culley, PharmD, BCPS, Bryan J. McCreery, PharmD Candidate, and Nicole T. Ansani, PharmD
PDF version: 
The authors compare and contrast the safety and efficacy of the newer insulin products—insulin aspart (NovoLog®), lispro (Humalog®), and glargine (Lantus®)—with existing human insulin (e.g., Humulin®, Novolin®).